Edition:
United States

Idorsia Ltd (IDIA.S)

IDIA.S on Swiss Exchange

23.10CHF
11:30am EDT
Change (% chg)

CHF0.00 (+0.00%)
Prev Close
CHF23.10
Open
CHF23.10
Day's High
CHF23.28
Day's Low
CHF23.10
Volume
130,327
Avg. Vol
420,990
52-wk High
CHF30.70
52-wk Low
CHF10.00

Select another date:

Thu, Apr 19 2018

BRIEF-Idorsia: US GAAP Oper Loss Of CHF 74 Mln In Q1 2018

* IDORSIA ANNOUNCES FINANCIAL RESULTS FOR THE FIRST QUARTER 2018

BRIEF-Idorsia FY US GAAP Loss Of CHF 8 Million

* US GAAP OPERATING RESULTS 2017: YTD LOSS OF CHF 8 MILLION; Q4 PROFIT OF CHF 71 MILLION

Idorsia to get $230 million from J&J in latest hypertension deal

ZURICH Idorsia , the Swiss drugmaker spun off from Actelion after it was bought by Johnson & Johnson (J&J) , will receive a one-time payment of $230 million from J&J's Janssen unit as they partner on aprocitentan for resistant hypertension.

Idorsia to get $230 mln from J&J in latest hypertension deal

ZURICH, Dec 4 Idorsia, the Swiss drugmaker spun off from Actelion after it was bought by Johnson & Johnson (J&J), will receive a one-time payment of $230 million from J&J's Janssen unit as they partner on aprocitentan for resistant hypertension.

BRIEF-Idorsia Announces Collaboration With Janssen Biotech On Aprocitentan

* IDORSIA ANNOUNCES COLLABORATION WITH JANSSEN BIOTECH ON APROCITENTAN (ACT-132577)

Select another date: